Wendy Wilbur
Gerontology · Purcell, OKNPI 1437648201
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Vanda Pharmaceuticals Inc. accounts for 69.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $712 and has fallen 66.2% since, to $241 in 2023.
Across 70 payments — averaging $23.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$1K
- Otsuka America Pharmaceutical, Inc.$220
- AbbVie$109
- Takeda Pharmaceuticals U.S.A., Inc.$84
- Acadia Pharmaceuticals Inc$45
- Lundbeck LLC$22
- plus $25 from 2 others
What the payments were for
- Food & beverage$1,646100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 43 | $1,140 |
| Otsuka America Pharmaceutical, Inc. | 11 | $220 |
| AbbVie | 6 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $84 |
| Acadia Pharmaceuticals Inc | 3 | $45 |
| Lundbeck LLC | 1 | $22 |
| Eisai Inc. | 1 | $13 |
| Neurocrine Biosciences, Inc. | 1 | $12 |
How this compares
$1,646 in reported general payments places this provider in the 60th percentile of 73 gerontology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $25,049 |
| TrulicityDulaglutide | 14 | $20,920 |
| OzempicSemaglutide | 13 | $19,377 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 45 | $1,348 |
| Gabapentin | 84 | $1,267 |
| Aripiprazole | 11 | $1,009 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $695 |
| Potassium Chloride | 43 | $655 |
| Omeprazole | 39 | $591 |
| Levothyroxine Sodium | 69 | $536 |
| Silver Sulfadiazine | 12 | $497 |
| Rosuvastatin Calcium | 12 | $401 |
| Nystatin | 23 | $350 |
| Pantoprazole Sodium | 27 | $347 |
| Duloxetine Hcl | 16 | $317 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Purcell
- Diane DewbrePurcell$213
- Whitney SimmonsOklahoma City$40K
- Christy CovingtonOklahoma City$12K
- Amanda SpencerNorman$8K
- Shelley TriplettTulsa$7K
- Stacie HanesOklahoma City$6K
- Justin RobertsMuskogee$6K
- Kelly SpychalskiAda$6K
- Samantha TuckerNorman$6K
- Kjerista TiptonTulsa$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.